Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Coronary Syndrome | 34 | 2017 | 210 | 3.230 |
Why?
|
| Myocardial Infarction | 29 | 2018 | 515 | 2.380 |
Why?
|
| Emergency Service, Hospital | 38 | 2018 | 502 | 2.030 |
Why?
|
| Platelet Aggregation Inhibitors | 14 | 2015 | 94 | 1.660 |
Why?
|
| Chest Pain | 20 | 2018 | 232 | 1.560 |
Why?
|
| Anticoagulants | 13 | 2015 | 143 | 1.110 |
Why?
|
| Body Surface Potential Mapping | 4 | 2012 | 14 | 0.970 |
Why?
|
| Electrocardiography | 26 | 2016 | 657 | 0.960 |
Why?
|
| Risk Assessment | 23 | 2016 | 1506 | 0.870 |
Why?
|
| Emergency Medicine | 6 | 2010 | 123 | 0.790 |
Why?
|
| Myocardial Ischemia | 8 | 2012 | 114 | 0.760 |
Why?
|
| Critical Pathways | 5 | 2018 | 52 | 0.720 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 13 | 2013 | 47 | 0.670 |
Why?
|
| Hospitalists | 3 | 2008 | 9 | 0.620 |
Why?
|
| Emergency Treatment | 5 | 2010 | 42 | 0.600 |
Why?
|
| Registries | 15 | 2016 | 328 | 0.590 |
Why?
|
| Practice Guidelines as Topic | 13 | 2011 | 429 | 0.510 |
Why?
|
| Humans | 76 | 2018 | 34475 | 0.510 |
Why?
|
| Angina, Unstable | 6 | 2007 | 22 | 0.490 |
Why?
|
| Middle Aged | 52 | 2018 | 12703 | 0.490 |
Why?
|
| Aged | 45 | 2018 | 10999 | 0.460 |
Why?
|
| Male | 57 | 2018 | 20697 | 0.460 |
Why?
|
| Decision Support Techniques | 4 | 2017 | 136 | 0.440 |
Why?
|
| Female | 55 | 2018 | 21491 | 0.420 |
Why?
|
| Myocardial Revascularization | 6 | 2016 | 42 | 0.410 |
Why?
|
| Health Services Accessibility | 3 | 2010 | 260 | 0.410 |
Why?
|
| Thrombosis | 3 | 2009 | 88 | 0.400 |
Why?
|
| Troponin | 10 | 2016 | 114 | 0.400 |
Why?
|
| Angina Pectoris | 3 | 2013 | 24 | 0.380 |
Why?
|
| Coronary Disease | 7 | 2007 | 239 | 0.380 |
Why?
|
| Professional Competence | 1 | 2012 | 18 | 0.370 |
Why?
|
| Peptide Fragments | 8 | 2015 | 430 | 0.370 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 38 | 0.370 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 53 | 0.360 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 168 | 0.350 |
Why?
|
| United States | 23 | 2016 | 4267 | 0.350 |
Why?
|
| Guideline Adherence | 8 | 2011 | 122 | 0.350 |
Why?
|
| Cardiology | 4 | 2016 | 110 | 0.340 |
Why?
|
| Severity of Illness Index | 6 | 2016 | 922 | 0.340 |
Why?
|
| Coronary Thrombosis | 2 | 2008 | 14 | 0.330 |
Why?
|
| Algorithms | 4 | 2012 | 560 | 0.330 |
Why?
|
| Transportation of Patients | 1 | 2010 | 25 | 0.330 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2010 | 35 | 0.320 |
Why?
|
| Exercise Test | 5 | 2016 | 247 | 0.320 |
Why?
|
| Enoxaparin | 7 | 2015 | 21 | 0.320 |
Why?
|
| Coronary Artery Disease | 3 | 2008 | 441 | 0.310 |
Why?
|
| Coronary Artery Bypass | 8 | 2015 | 112 | 0.310 |
Why?
|
| Time Factors | 16 | 2016 | 2352 | 0.310 |
Why?
|
| Cardiology Service, Hospital | 3 | 2015 | 23 | 0.310 |
Why?
|
| Education, Medical, Continuing | 5 | 2014 | 58 | 0.300 |
Why?
|
| Hirudins | 8 | 2015 | 19 | 0.300 |
Why?
|
| Clinical Protocols | 4 | 2016 | 87 | 0.300 |
Why?
|
| Heparin | 7 | 2013 | 74 | 0.300 |
Why?
|
| Sensitivity and Specificity | 8 | 2017 | 612 | 0.300 |
Why?
|
| Heart Diseases | 2 | 2011 | 124 | 0.290 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2009 | 67 | 0.280 |
Why?
|
| Creatine Kinase, MB Form | 7 | 2007 | 9 | 0.280 |
Why?
|
| Fibrinolytic Agents | 5 | 2009 | 71 | 0.280 |
Why?
|
| Antithrombins | 3 | 2015 | 5 | 0.280 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2008 | 35 | 0.270 |
Why?
|
| Adult | 21 | 2018 | 10015 | 0.270 |
Why?
|
| Continuity of Patient Care | 1 | 2008 | 75 | 0.260 |
Why?
|
| Aspirin | 6 | 2010 | 65 | 0.260 |
Why?
|
| Treatment Outcome | 15 | 2015 | 3618 | 0.260 |
Why?
|
| Predictive Value of Tests | 10 | 2017 | 934 | 0.250 |
Why?
|
| Hemorrhage | 6 | 2015 | 109 | 0.240 |
Why?
|
| Syncope | 1 | 2006 | 28 | 0.230 |
Why?
|
| Clinical Competence | 2 | 2009 | 349 | 0.230 |
Why?
|
| Patient Selection | 2 | 2011 | 291 | 0.220 |
Why?
|
| Credentialing | 1 | 2004 | 9 | 0.210 |
Why?
|
| Politics | 1 | 2004 | 22 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 152 | 0.210 |
Why?
|
| Patient Discharge | 4 | 2015 | 214 | 0.210 |
Why?
|
| North Carolina | 8 | 2016 | 1612 | 0.210 |
Why?
|
| Recombinant Proteins | 8 | 2015 | 281 | 0.200 |
Why?
|
| Pacemaker, Artificial | 1 | 2004 | 42 | 0.200 |
Why?
|
| Pesticides | 1 | 2016 | 201 | 0.200 |
Why?
|
| Ticlopidine | 5 | 2009 | 17 | 0.200 |
Why?
|
| Hospital Mortality | 7 | 2009 | 207 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 237 | 0.200 |
Why?
|
| Reproducibility of Results | 5 | 2016 | 819 | 0.200 |
Why?
|
| Clinical Trials as Topic | 4 | 2008 | 325 | 0.190 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 248 | 0.190 |
Why?
|
| Survival Analysis | 6 | 2013 | 509 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 304 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 1386 | 0.190 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 4151 | 0.190 |
Why?
|
| Delivery of Health Care | 3 | 2014 | 174 | 0.180 |
Why?
|
| Heart Conduction System | 3 | 2008 | 80 | 0.180 |
Why?
|
| Risk Factors | 12 | 2017 | 4136 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2008 | 837 | 0.180 |
Why?
|
| Troponin T | 4 | 2007 | 98 | 0.180 |
Why?
|
| Peptides | 4 | 2013 | 142 | 0.170 |
Why?
|
| Patient Care Team | 2 | 2014 | 130 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2017 | 1910 | 0.170 |
Why?
|
| Logistic Models | 10 | 2010 | 808 | 0.160 |
Why?
|
| Evidence-Based Medicine | 5 | 2011 | 230 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2016 | 2461 | 0.160 |
Why?
|
| Patient Admission | 2 | 2011 | 59 | 0.160 |
Why?
|
| Acute Disease | 8 | 2011 | 276 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2016 | 948 | 0.160 |
Why?
|
| Creatine Kinase | 3 | 2003 | 11 | 0.150 |
Why?
|
| Coronary Angiography | 4 | 2018 | 168 | 0.150 |
Why?
|
| Isoenzymes | 3 | 2003 | 72 | 0.150 |
Why?
|
| Quality of Health Care | 3 | 2010 | 155 | 0.140 |
Why?
|
| Odds Ratio | 7 | 2011 | 480 | 0.140 |
Why?
|
| Early Diagnosis | 2 | 2008 | 62 | 0.130 |
Why?
|
| Diagnostic Errors | 2 | 2009 | 44 | 0.130 |
Why?
|
| Troponin C | 1 | 2017 | 9 | 0.130 |
Why?
|
| Observation | 2 | 2013 | 25 | 0.120 |
Why?
|
| Drug Therapy, Combination | 4 | 2015 | 318 | 0.120 |
Why?
|
| Triage | 3 | 2009 | 76 | 0.120 |
Why?
|
| Pyridines | 2 | 2013 | 87 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 101 | 0.120 |
Why?
|
| Death | 1 | 2015 | 53 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2016 | 126 | 0.110 |
Why?
|
| Prognosis | 7 | 2016 | 1603 | 0.110 |
Why?
|
| Cause of Death | 3 | 2016 | 245 | 0.110 |
Why?
|
| Hospitalization | 3 | 2010 | 500 | 0.110 |
Why?
|
| Age Factors | 5 | 2016 | 1262 | 0.110 |
Why?
|
| Documentation | 2 | 2004 | 44 | 0.110 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 2366 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2016 | 3812 | 0.100 |
Why?
|
| Decision Making | 1 | 2016 | 203 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 565 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2013 | 597 | 0.100 |
Why?
|
| Cyclic N-Oxides | 1 | 2013 | 8 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 69 | 0.100 |
Why?
|
| Heart Failure | 4 | 2007 | 780 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 540 | 0.090 |
Why?
|
| Troponin I | 3 | 2007 | 25 | 0.090 |
Why?
|
| Observer Variation | 1 | 2012 | 108 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2008 | 589 | 0.090 |
Why?
|
| Syndrome | 4 | 2007 | 76 | 0.090 |
Why?
|
| Health Personnel | 2 | 2011 | 131 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 75 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2012 | 214 | 0.090 |
Why?
|
| Singapore | 5 | 2016 | 12 | 0.090 |
Why?
|
| Cardiovascular Agents | 2 | 2009 | 22 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2011 | 51 | 0.090 |
Why?
|
| Health Expenditures | 1 | 2011 | 71 | 0.090 |
Why?
|
| Length of Stay | 4 | 2015 | 335 | 0.080 |
Why?
|
| Patient Care | 1 | 2011 | 29 | 0.080 |
Why?
|
| Regional Health Planning | 1 | 2010 | 9 | 0.080 |
Why?
|
| Inpatients | 1 | 2011 | 88 | 0.080 |
Why?
|
| Critical Care | 1 | 2011 | 113 | 0.080 |
Why?
|
| Thrombolytic Therapy | 2 | 2008 | 67 | 0.080 |
Why?
|
| Women | 1 | 2010 | 13 | 0.080 |
Why?
|
| Organizational Innovation | 1 | 2010 | 34 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 364 | 0.080 |
Why?
|
| Program Development | 1 | 2010 | 98 | 0.080 |
Why?
|
| Minority Groups | 1 | 2010 | 90 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2010 | 190 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2016 | 924 | 0.080 |
Why?
|
| Polysaccharides | 1 | 2009 | 14 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2009 | 46 | 0.070 |
Why?
|
| Internet | 2 | 2007 | 207 | 0.070 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 41 | 0.070 |
Why?
|
| Emergency Medical Services | 2 | 2010 | 189 | 0.070 |
Why?
|
| Attitude of Health Personnel | 2 | 2009 | 193 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1209 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2007 | 10 | 0.070 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 20 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 90 | 0.060 |
Why?
|
| Incidence | 3 | 2016 | 1289 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 183 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 4 | 2007 | 120 | 0.060 |
Why?
|
| Sex Factors | 2 | 2005 | 707 | 0.060 |
Why?
|
| Insurance, Health | 2 | 2004 | 98 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 295 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2011 | 155 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 287 | 0.060 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2005 | 109 | 0.060 |
Why?
|
| Professional Autonomy | 1 | 2004 | 6 | 0.050 |
Why?
|
| Reimbursement Mechanisms | 1 | 2004 | 13 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2004 | 19 | 0.050 |
Why?
|
| Specialty Boards | 1 | 2004 | 11 | 0.050 |
Why?
|
| Cost Savings | 2 | 2016 | 38 | 0.050 |
Why?
|
| Malpractice | 1 | 2004 | 22 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2004 | 20 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2004 | 36 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2004 | 43 | 0.050 |
Why?
|
| Survival Rate | 2 | 2016 | 925 | 0.050 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 113 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2004 | 82 | 0.050 |
Why?
|
| Total Quality Management | 1 | 2002 | 19 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1010 | 0.050 |
Why?
|
| ROC Curve | 2 | 2016 | 176 | 0.040 |
Why?
|
| Comorbidity | 3 | 2009 | 596 | 0.040 |
Why?
|
| American Medical Association | 2 | 2011 | 5 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 304 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2009 | 191 | 0.040 |
Why?
|
| Forecasting | 2 | 2010 | 153 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2008 | 17 | 0.030 |
Why?
|
| Tyrosine | 2 | 2008 | 28 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2016 | 41 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 270 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 149 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2006 | 194 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 28 | 0.030 |
Why?
|
| Age Distribution | 2 | 2006 | 211 | 0.030 |
Why?
|
| Research Design | 2 | 2007 | 337 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 703 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 2004 | 43 | 0.030 |
Why?
|
| Stents | 2 | 2008 | 167 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 378 | 0.030 |
Why?
|
| Consensus | 2 | 2004 | 91 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 35 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 101 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 110 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 18 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 325 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2003 | 103 | 0.020 |
Why?
|
| Telecommunications | 1 | 2011 | 7 | 0.020 |
Why?
|
| Peer Review, Health Care | 1 | 2011 | 8 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 30 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 141 | 0.020 |
Why?
|
| Staff Development | 1 | 2011 | 16 | 0.020 |
Why?
|
| Coronary Care Units | 1 | 2011 | 7 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 21 | 0.020 |
Why?
|
| Drug Costs | 1 | 2011 | 51 | 0.020 |
Why?
|
| Adenosine | 1 | 2011 | 74 | 0.020 |
Why?
|
| Dobutamine | 1 | 2011 | 71 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 803 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2010 | 5 | 0.020 |
Why?
|
| State Health Plans | 1 | 2010 | 5 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 202 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 199 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 191 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 464 | 0.020 |
Why?
|
| Bradycardia | 1 | 2009 | 19 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2009 | 53 | 0.020 |
Why?
|
| Hypotension | 1 | 2009 | 49 | 0.020 |
Why?
|
| Benchmarking | 1 | 2009 | 26 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2010 | 168 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 306 | 0.020 |
Why?
|
| Thiophenes | 1 | 2008 | 25 | 0.020 |
Why?
|
| Atherectomy | 1 | 2008 | 4 | 0.020 |
Why?
|
| Piperazines | 1 | 2008 | 64 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2008 | 128 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 31 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 138 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2007 | 63 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1607 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 103 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 984 | 0.020 |
Why?
|
| Medical Records | 1 | 2006 | 81 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 87 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 191 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 184 | 0.010 |
Why?
|
| Physicians | 1 | 2006 | 167 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2003 | 100 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 440 | 0.010 |
Why?
|
| Creatinine | 1 | 2003 | 206 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2004 | 115 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 2004 | 245 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1034 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 583 | 0.010 |
Why?
|
| African Americans | 1 | 2003 | 1435 | 0.010 |
Why?
|